Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yulan Li

Showing results (11-20 of 160) with videos related to

Pageof 16
Sort By:
Scientific Reports|July 27, 2025
Identification and validation of biomarkers associated with glycolysis in polycystic ovarian syndromeRongyan Zhu, Xiao Yu, Yulan Li
Frontiers in Cell and Developmental Biology|December 8, 2025
PARP9 drives the malignant progression of pancreatic cancer cells by regulating apoptosis, DNA damage, and multidrug efflux systemsXing Wang, Xiaolong Liu, Yulan Li
Journal of Biopharmaceutical Statistics|June 12, 2014
On robustness of noninferiority clinical trial designs against bias, variability, and nonconstancyQing Liu, Yulan Li, Katherine Odem-Davis
Journal of Inflammation Research|May 11, 2026
Macrophage Phenotypic Plasticity and Inflammatory Mechanisms in Hyperoxia-Induced Lung InjuryWei Fu, Yawei Yao, Tingyang Meng, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|June 13, 2026
Development and validation of a nomogram integrating exfoliative cell DNA ploidy and inflammatory-nutritional markers for the prediction of high-grade dysplasia in oral leukoplakia: a cross-sectional diagnostic studyCaiyun Liu, Hongtao Wang, Yulan Li, et al.
Pharmaceutical Statistics|June 19, 2018
Sample size allocation in multiregional equivalence studiesJason J Z Liao, Ziji Yu, Yulan Li
Statistics in Medicine|September 20, 2012
Statistical considerations in biosimilar clinical efficacy trials with asymmetrical marginsYulan Li, Qing Liu, Patricia Wood, et al.
Frontiers in Public Health|August 2, 2024
Comprehensive evaluation of global health cities development levelsYu Wen, Yulan Li, Yan Zhang, et al.
Journal of Biopharmaceutical Statistics|June 2, 2012
On adaptive error spending approach for group sequential trials with random information levelsQing Liu, Pilar Lim, Issac Nuamah, et al.
Scientific Reports|February 5, 2025
Machine learning-random forest model was used to construct gene signature associated with cuproptosis to predict the prognosis of gastric cancerXiaolong Liu, Pengxian Tao, He Su, et al.
Pageof 16

Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Scientific Reports|July 27, 2025
Identification and validation of biomarkers associated with glycolysis in polycystic ovarian syndromeRongyan Zhu, Xiao Yu, Yulan Li
Frontiers in Cell and Developmental Biology|December 8, 2025
PARP9 drives the malignant progression of pancreatic cancer cells by regulating apoptosis, DNA damage, and multidrug efflux systemsXing Wang, Xiaolong Liu, Yulan Li
Journal of Biopharmaceutical Statistics|June 12, 2014
On robustness of noninferiority clinical trial designs against bias, variability, and nonconstancyQing Liu, Yulan Li, Katherine Odem-Davis
Journal of Inflammation Research|May 11, 2026
Macrophage Phenotypic Plasticity and Inflammatory Mechanisms in Hyperoxia-Induced Lung InjuryWei Fu, Yawei Yao, Tingyang Meng, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|June 13, 2026
Development and validation of a nomogram integrating exfoliative cell DNA ploidy and inflammatory-nutritional markers for the prediction of high-grade dysplasia in oral leukoplakia: a cross-sectional diagnostic studyCaiyun Liu, Hongtao Wang, Yulan Li, et al.
Pharmaceutical Statistics|June 19, 2018
Sample size allocation in multiregional equivalence studiesJason J Z Liao, Ziji Yu, Yulan Li
Statistics in Medicine|September 20, 2012
Statistical considerations in biosimilar clinical efficacy trials with asymmetrical marginsYulan Li, Qing Liu, Patricia Wood, et al.
Frontiers in Public Health|August 2, 2024
Comprehensive evaluation of global health cities development levelsYu Wen, Yulan Li, Yan Zhang, et al.
Journal of Biopharmaceutical Statistics|June 2, 2012
On adaptive error spending approach for group sequential trials with random information levelsQing Liu, Pilar Lim, Issac Nuamah, et al.
Scientific Reports|February 5, 2025
Machine learning-random forest model was used to construct gene signature associated with cuproptosis to predict the prognosis of gastric cancerXiaolong Liu, Pengxian Tao, He Su, et al.
Pageof 16